- Home
- THCH vs ZTEK Comparison
THCH vs ZTEK Comparison
Compare THCH & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THCH | ZTEK |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Blank Checks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.7M | 78.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | THCH | ZTEK |
|---|---|---|
| Price | $2.27 | $0.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.1K | ★ 94.4K |
| Earning Date | 12-09-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $188,274,078.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $1.95 | $0.62 |
| 52 Week High | $3.80 | $1.84 |
Technical Indicators
Market Signals| Indicator | THCH | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 47.97 | 55.39 |
| Support Level | $2.08 | $0.85 |
| Resistance Level | $2.66 | $1.09 |
| Average True Range (ATR) | 0.13 | 0.08 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 41.38 | 47.22 |
Price Performance
Historical ComparisonAbout THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.